|
Volume 270,
Number 49,
Issue of December 8, 1995 pp. 29182-29188
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Each Domain of
the N-Ethylmaleimide-sensitive Fusion Protein Contributes to
Its Transport Activity (*)
(Received for publication, August 1, 1995; and in revised form, August 30, 1995)
Elzbieta E.
Nagiec
,
Audrey
Bernstein
,
Sidney W.
Whiteheart (§)
From the Department of Biochemistry, University of Kentucky
College of Medicine, Chandler Medical Center, Lexington, Kentucky
40536-0084
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
N-Ethylmaleimide-sensitive fusion protein (NSF) has
been shown to be involved in numerous intracellular transport events.
In an effort to understand the basic mechanism of NSF in vesicle-target
membrane fusion events, we have examined the role that each of its
three domains play in how NSF interacts with the SNAP SNARE
complex. Mutagenesis of the first ATP-binding domain (D1, amino acids
206-477) demonstrates that nucleotide binding by this domain is
required for 20 S particle assembly. A second mutation, which permits
ATP binding but not hydrolysis, yields a protein that can form 20 S
particle but fails to mediate its disassembly. Similar mutations of the
second ATP-binding domain (D2, amino acids 478-744) result in
trimeric molecules that behave like wild type NSF. Domain rearrangement
mutants were used to further probe the functional role of each domain.
The amino-terminal domain (N, amino acids 1-205) is absolutely
required for binding of NSF to the SNAP SNARE complex, because the
truncated mutant, D1D2, is unable to form 20 S particle. When tested as
an isolated recombinant protein, the N domain is not sufficient for
binding to the SNAP SNARE complex, but when adjacent to the D1
domain or in a trimeric molecule, the N domain does mediate binding to
the SNAP SNARE complex. Monomeric N-D1 and trimeric N-D2 could
both participate in particle formation. Only the N-D1 mutant was able
to facilitate MgATP-dependent release from the SNAP SNARE complex.
These data demonstrate that NSF binding to the SNAP SNARE complex
is mediated by the N domain and that both ATP binding and hydrolysis by
the D1 domain are essential for 20 S particle dynamics. The
intramolecular interactions outlined suggest a mechanism by which NSF
may use ATP hydrolysis to facilitate the vesicle fusion process.
INTRODUCTION
Several groups have now shown a requirement for the N-ethylmaleimide-sensitive fusion protein (NSF/Sec18p) ( )in numerous intracellular fusion events of both regulated
and constitutive secretion (reviewed in (1) ). Kinetic
analysis, using the intra-Golgi transport assay, shows that NSF/Sec18p
acts at a late stage in the transport process. N-Ethylmaleimide inhibition of intra-Golgi transport leads to
an accumulation of uncoated vesicles that appear to be consumed upon
the addition of pure NSF(2) . Studies with the
temperature-sensitive mutant alleles, sec18-1 or sec18-2, show that under restrictive conditions there is
also a build-up of 50 nm vesicles(3) . These results
demonstrate that NSF/Sec18p is required for vesicle consumption and
suggest that it is involved at or near the actual vesicle-target
membrane fusion step. Recent experiments have pointed to a role for NSF
in earlier stages, such as vesicle formation or
priming(4, 5) . However, these data conflict with
other experiments (6, 7) that show that NSF/Sec18p is
not required for production of active transport vesicles in
vitro. Although its precise function remains to be elucidated, it
is clear that NSF is a general transport factor that plays a central
role in many (though perhaps not all; (8) ) of the heterotypic
fusion events in the cell. To explain heterotypic fusion events,
Rothman and colleagues proposed the SNAP Receptor (SNARE)
hypothesis(9) , in which the specificity of vesicle-target
membrane docking is mediated by the matching of a t-SNARE from the
target membrane with its cognate v-SNARE in the vesicle membrane,
thereby forming a docking or 7 S complex. This complex then provides
binding sites for the soluble NSF attachment proteins (SNAPs), which
are absolutely required to mediate the correct positioning of
NSF(10, 11, 12, 13) . This last step
serves to complete the formation of the so-called 20 S fusion particle.
At least part of the energy for membrane fusion is thought to be
provided by the hydrolysis of ATP by NSF, because mutant forms of NSF
that are unable to hydrolyze ATP also fail to complete the vesicular
transport process(14) . To describe the molecular basis of
vesicle-target membrane fusion, it becomes critical to understand how
NSF interacts with the other elements of the fusion machinery (SNAPs,
SNAREs, etc.) and how it might use the energy from ATP
hydrolysis to facilitate membrane fusion. The subunit of the
homotrimeric NSF can be divided into three domains: an amino-terminal
(N, amino acids 1-205) and two ATP-binding domains (D1, amino
acids 206-477, and D2, amino acids
478-744)(15, 16) . Initially delineated by
sequence analysis, these domains probably represent discrete structural
entities because they are released by limited proteolysis of the intact
molecule(16) . Mutations in the ATP-binding site of domain D1
(binding mutants Lys to Ala (D1K-A), Gln, or Met or
hydrolysis mutant Glu to Gln (D1E-Q)) eliminate
intra-Golgi transport activity and cause a 70-80% decrease in
ATPase activity relative to wild type NSF(14, 17) .
These mutant proteins inhibit intra-Golgi transport in a competitive
fashion that as demonstrated in this manuscript (see Fig. 1), is
most likely due to their ability to form 20 S fusion particle but not
mediate MgATP-dependent particle disassembly. The D2 domain is required
for trimerization, but its ability to bind (mutant Lys to
Ala (D2K-A), Gln, or Met) or hydrolyze (mutant Asp to Gln
(D2D-Q)) ATP does not seem to be specifically required for intra-Golgi
transport(14, 17) . The ATP hydrolytic activity of
this domain makes only a small contribution to the overall ATPase
activity of NSF (30-40%)(14) . The amino-terminal domain
has been proposed to exert some control over the ATPase activity of NSF
because antibodies directed against it cause a 2-fold increase in
hydrolytic activity(17) . A similar increase in ATPase activity
was observed when NSF was bound to SNAPs that had been immobilized on a
plastic surface(18) . We present data demonstrating that the N
domain of NSF is required for interaction with the rest of the 20 S
particle components. Deletion of this domain results in a trimeric
molecule (D1D2) with ATPase activity but no ability to bind to the
SNAP SNARE complex. It has been suggested that each of the three
domains of NSF has a distinct contribution to the overall activity of
the NSF trimer. In this manuscript we propose a role for the N domain
in NSF binding to the SNAP SNARE complex and demonstrate the
importance of nucleotide binding and hydrolysis by the D1 domain to 20
S particle dynamics. Further dissection of the role of these domains
will undoubtedly shed new light on the cellular function of NSF and may
elucidate new aspects of the heterotypic fusion process.
Figure 1:
A, 20 S Particle formation and
disassembly as measured by the SNARE-dependent association of
[ S] -SNAP with mutant or wild type NSF.
Mutant or wild type NSF (15 µg) with the carboxyl-terminal myc epitope were incubated with radiolabeled -SNAP in either the
presence or the absence of bovine brain extract (120 µg), which was
used as a source of SNARE proteins (SNAREs). Either 0.5 mM ATP (ATP) or ATP S (ATP S) was added to
the reactions, and all were maintained in 5 mM MgCl . Anti-myc antibody coupled to protein
G-Superose beads was then added, and the immunoprecipitated complexes
were collected on glass fiber filters and quantified by scintillation
counting. The error bars represent the range of two separate
experiments. Abbreviations for the NSF mutants are explained in the
text and in Fig. 2. B, MgATP-dependent release of
syntaxin from 20 S particle containing either mutant or wild type NSF.
Incubations were performed with 0.5 mM ATP S as above
except unlabeled -SNAP (54 µg) was added. The complexes were
immunoprecipitated and washed in binding buffer. The resulting beads
were then incubated with either 5 mM ATP (ATP) or
ATP S (ATP S) with 5 mM MgCl , and
the proteins released into the supernatant were concentrated and
subjected to SDS-polyacrylamide gel electrophoresis and Western
blotting using the anti-syntaxin antibody HPC1. Another set of beads
was eluted with 0.2 M glycine to determine the total amount of
protein bound (Total). The blots presented are representative
of two separate experiments.
Figure 2:
A, schematic representation of the domain
rearrangement mutants. Domain rearrangement mutants were constructed
and purified as outlined in Whiteheart et al.(14) .
Depicted are the arrangements of the domains in a given mutant subunit
together with the abbreviated name of the mutant listed at left. The right column indicates the trimeric state
of the recombinant protein. B, point mutations of the D1 and
D2 domain ATP-binding sites. The sequences of the D1 and D2 domain
ATP-binding sites are depicted with the two point mutations, underlined for both domains. Lysine 266 and 549 were changed
to alanine residues as described(14) , and the resulting mutant
proteins were denoted D1K-A and D2K-A, respectively. Glutamic acid 329
and aspartic acid 604 were changed to glutamine residues(14) ,
and the resulting mutant proteins were denoted D1E-Q and D2D-Q
respectively. A mutant containing both changes was also used and
denoted D1E-Q/D2D-Q.
EXPERIMENTAL PROCEDURES
MaterialsThe monoclonal antibodies,
9E10 (ATCC CRL 1729; (19) ) and 6E6 (17) were prepared
from tissue culture supernatants. Anti-amino-terminal domain antibodies
were produced in rabbits after immunization with the recombinant N
domain and were used as crude sera. HPC1 (20) was prepared from
ascites and was a generous gift of Drs. James Rothman and Thomas
Söllner. Antibodies for immunoprecipitation were
covalently coupled to beads by initially binding the relevant
antibodies to protein G-Sepharose 4 Fast Flow (Pharmacia Biotech Inc.)
followed by cross-linking with dimethyl pimelimidate
(Pierce)(21) . -SNAP was purified by NiNTA-agarose (QIAGEN
Inc., Chatsworth, CA) affinity chromatography as described
previously(22) . Bovine brain extract was prepared as described (9) and dialyzed against 25 mM Tris/HCl, pH 7.8, 50
mM KCl, 1 mM 1,4-dithiothreitol, and 1% Triton X-100
before use. In vitro translation of
[ S] -SNAP was performed as described
previously, and the radiolabeled protein was partially purified by
ammonium sulfate precipitation(23) . The protein concentration
of the bovine brain extract preparation was determined by the
bicinchoninic acid assay (Pierce) using bovine serum albumin as
standard; all other protein concentrations were determined using the
Bio-Rad protein assay reagent and ovalbumin as a standard. All
chemicals were of reagent grade.
Production and Purification of NSF
MutantsThe point mutation and domain rearrangement mutants
of NSF were constructed as described previously(14) , cloned
into pQE-9 (QIAGEN), and expressed in Escherichia coli after
induction with 1 mM isopropyl-thio- -galactoside
(Boehringer Mannheim). For the experiments in Fig. 1, all
mutants were constructed with a carboxyl-terminal myc epitope
that allows immunoprecipitation of the recombinant protein by the 9E10
antibody (19) . This epitope has been shown to have no effect
on the activity of the wild type NSF molecule(24) . For
purification of the recombinant proteins, E. coli cells were
disrupted using a French press, insoluble material was removed by
centrifugation, and the His -tagged proteins were purified
by NiNTA-agarose (QIAGEN) affinity chromatography as
described(22) . Additional purification for ATPase studies or
for characterization of the oligomeric state of the mutant proteins was
performed by gel exclusion chromatography on Superose 6 (Pharmacia; 1.5
45 cm, 0.5 ml/min) in 10 mM HEPES/NaOH, pH 7.0, 300
mM NaCl, 2 mM -mercaptoethanol, 0.5 mM ATP, 0.5 mM MgCl , and 5% glycerol. This
buffer appeared to stabilize trimeric NSF more effectively than
previously used buffer systems.
20 S Particle Formation and Disassembly
AssaysTwo basic types of assays were used to measure 20 S
particle formation and disassembly. In the first assay, based on Wilson et al.(12) , particle formation was assessed by the
association of S-radiolabeled -SNAP with wild type or
mutant NSF in a SNARE-dependent fashion. For this assay, particle was
formed and then immunoprecipitated through the myc epitope by
the 9E10 antibody coupled to beads. The complexes were collected on
glass fiber filters, and the [ S] -SNAP bound
was quantified by liquid scintillation counting. In a permutation of
this assay, excess unlabeled -SNAP was used, and the resulting
complexes were isolated by immunoprecipitation. The beads were then
incubated in buffer containing either 5 mM ATP or ATP S
and 5 mM MgCl for 30 min on ice. The release of
complex components into the supernatant was determined by Western
blotting using the anti-syntaxin antibody (HPC1). For the second type
of assay, based on the work of Söllner et
al.(13) , complexes were formed with -SNAP, SNAREs
from bovine brain extract, and NSF (or mutant form) then
immunoprecipitated using the anti-syntaxin antibody HPC1. For these
experiments, ATP S or ATP was added during the formation phase of
the reaction. After immunoprecipitation, the proteins
co-immunoprecipitated by HPC1 were eluted by 0.2 M glycine, pH
2.7, and 1% Triton X-100 and analyzed by Western blotting. Each type of
reaction (final volume, 500 µl) was carried out in 20 mM
HEPES/KOH, pH 7.0, 100 mM KCl, 1% Triton X-100, 1 mM 1,4-dithiothreitol, 1% polyethylene glycol, and 1% glycerol with
ATP S, ATP, or MgCl as noted in the legend. Particle
formation was allowed to occur on ice for 45 min. The reactions were
clarified by centrifugation (8 min at 14,000 g), and
the supernatants were incubated with the relevant antibody conjugate
for 2 h with gentle rotation. In experiments done with HPC1, >70% of
the available syntaxin protein was immunoprecipitated; likewise,
>90% of the myc-tagged proteins were precipitated with the
9E10 antibodies coupled to beads. The amounts of all mutant proteins
were equalized based on protein assays and by Coomassie Brilliant Blue
staining after gel electrophoresis. Western blots were developed by
Enhanced Chemiluminescence (Amersham Corp.), and all exposures were
matched relative to a wild type NSF control, which was included in each
experiment. Shown in Fig. 3B is the immunodetection of
each NSF mutant. To ensure detection of all mutants, multiple antibody
probes were used due to the differences in the epitopes recognized by
the various antibodies (see Fig. 3B). Several of the
recombinant proteins were partially proteolyzed during preparation (see Fig. 3B). The data in Fig. 3A represent
only the full-length (as calculated from their sequence) proteins.
Figure 3:
A, SNAP-dependent binding of mutant or
wild type NSF to the SNARE complex. Mutant or wild type NSF (15 µg)
was incubated with bovine brain extract (200 µg) in the presence or
the absence (-SNAP) of -SNAP (5 µg) in the
presence of 0.5 mM ATP S (ATP S) or ATP (ATP). The resulting complexes were then precipitated using
anti-syntaxin antibody coupled to protein G-Superose. The bound
proteins were eluted with 0.2 M glycine and were analyzed by
SDS-polyacrylamide gel electrophoresis and Western blotting with
anti-NSF (Bound) or anti-syntaxin (Syntaxin)
antibodies. Unbound mutant or wild type NSF in the washes (Unbound) was also concentrated and analyzed by
SDS-polyacrylamide gel electrophoresis and Western blotting. The blots
presented are representative of at least two separate experiments.
Abbreviations for the NSF mutants are explained in the text and in Fig. 2. B, immunodetection of NSF rearrangement
mutants. Equal amounts of wild type and mutant NSF were blotted onto
nitrocellulose and immunodecorated with either the monoclonal 6E6
antibody (6E6) or the polyclonal anti-N domain antibody (anti-N). The bands were visualized with the appropriate
secondary antibody-horseradish peroxidase conjugates using Enhanced
Chemiluminescence. The apparent molecular mass of each full-length
protein was: wild type (wt), 82.2 kDa; ND2, 57.4 kDa; D1D2,
63.9 kDa; ND1, 61.6 kDa; N, 25 kDa; and ND2D1, 85.3
kDa.
Miscellaneous Assays of NSF
ActivityATPase assays were performed as described
previously (16) using [ - P]ATP in a
buffer containing 25 mM Tris/HCl, pH 9.0, 100 mM KCl,
0.5 mM 1,4-dithiothreitol, 1 mM MgCl , 10%
glycerol, 1 mM ATP, and 10 µCi of
[ - P]ATP (DuPont NEN). At given time points,
aliquots (2 µl) of each reaction were spotted on a
polyethyleneimine thin layer plate (J. T. Baker Inc., Phillipsburg, NJ)
and chromatographed in 0.7 M LiCl and 1 M acetic
acid. The spots corresponding to an ADP standard were excised and
quantified by liquid scintillation counting. In no assays was there a
significant amount of AMP formed. Intra-Golgi transport assays in a
final volume of 25 µl were performed as described
previously(25) . Briefly, Golgi membranes were prepared from
wild type Chinese hamster ovary cells and mutant 15B Chinese hamster
ovary cells (lacking GlcNAc transferase I) that had been previously
infected with vesicular stomatitis virus. Transport of a viral marker
protein from the mutant Golgi complex (donor) to the wild type Golgi
complex (acceptor) was measured by the incorporation of
[ H]GlcNAc into the vesicular stomatitis virus G
glycoprotein. Soluble components for transport activity were provided
by a cytosolic fraction prepared from wild type Chinese hamster ovary
cells. To measure NSF activity in transport, membranes were treated
with 1 mMN-ethylmaleimide for 15 min on ice prior to
use in the standard transport assay(26) .
RESULTS
Role of the ATP-binding Sites of NSF in 20 S
Particle Formation and DisassemblyThe basic configuration
of the SNARE assay of Wilson et al.(12) was used to
determine whether the ATP-binding domain mutants of NSF could
participate in 20 S particle formation and subsequent MgATP-mediated
particle disassembly. In the assay represented in Fig. 1A, the ability of an NSF mutant to form 20 S
particle was determined by measuring the amount of
[ S] -SNAP associated with immunoprecipitated
NSF myc (or mutant) in a SNARE-dependent fashion. For wild
type NSF, particle formation is maintained by the addition of the
nonhydrolyzable ATP S but is eliminated by MgATP in keeping with
the role that ATP hydrolysis is reported to play in particle
disassembly(12) . In a more sensitive permutation of this assay (Fig. 1B), 20 S particle containing NSF (or mutant) was
first formed under saturating conditions (excess unlabeled -SNAP
and SNAREs), immunoprecipitated with anti-myc antibodies, and
then incubated with either ATP S/Mg or MgATP to initiate particle
disassembly. Syntaxin 1 released from the particle was measured by
Western blotting and compared with the total syntaxin bound in the
particle.For both assay configurations (Fig. 1, A and B), neither ATP-binding site mutation (Lys-Ala or
Asp-Gln; see Fig. 2) in the D2 domain had any effect on 20 S
particle formation or the ATP hydrolysis-mediated dissolution of the
complex. Binding of radiolabeled -SNAP (Fig. 1A)
and syntaxin (Fig. 1B, Total) to the two
mutants, (D2K-A and D2D-Q), was essentially identical to the binding by
wild type NSF and the addition of MgATP-mediated release of particle
components (Fig. 1B, ATP). The D1D2 mutant
that lacks the N domain failed to support 20 S particle formation. D1D2
was unable to bind either the radiolabeled SNAP (Fig. 1A) or syntaxin (Fig. 1B, Total; also see Fig. 2A). Despite its trimeric
nature and ATPase activity (Table 1), the D1D2 mutant was not
active in intra-Golgi transport(14) , probably because it
cannot bind to the SNAP SNARE complex.
The ATP-binding mutant
D1K-A does not show any 20 S particle formation activity as measured by
the [ S] -SNAP binding assay (Fig. 1A). When binding was measured in a more
sensitive assay under saturating conditions, (Fig. 1B, Total) it appeared that the D1K-A mutant was approximately 10%
as efficient at 20 S particle formation as wild type NSF. In the
intra-Golgi transport assay, this mutant displayed no transport
activity but, interestingly, could inhibit transport when added at high
concentrations (IC = 157
nM)(14, 17) . This mutant showed <10% of
the inhibitory activity of the ATP hydrolysis mutants D1E-Q (IC = 9.4 nM) or the double mutant D1E-Q/D2D-Q
(IC 13.3 nM)(14) . These data suggest
that binding of a nucleotide by the D1 domain is an important element
of the overall binding of the NSF trimer to the SNAP SNARE
complex. The ATP hydrolysis mutants D1E-Q and D1E-Q/D2D-Q participate
in 20 S particle formation as does wild type NSF (Fig. 1, A and B, Total). However, when MgATP is added, the
particle formed does not disassemble (Fig. 1, A and B, ATP). Because both mutants are inhibitory to
intra-Golgi transport (14) but can form 20 S particle, it seems
likely that the MgATP-mediated disassembly step by the NSF trimer is a
required intermediate in the vesicular transport process and that the
ATPase activity of the D1 domain is crucial to that step.
Differential Role of NSF Domains in 20 S Particle
FormationFrom the data of Fig. 1, it is clear that
the N domain is an important element in NSF binding to the
SNAP SNARE complex. To determine what structural elements of the
NSF trimer are important for 20 S complex formation, we examined a
series of truncation and domain rearrangement mutants (Fig. 2)
using an assay similar to the one employed by
Söllner et al.(13) . In this
assay, mutant proteins were incubated with excess -SNAP and a
detergent-solubilized preparation of bovine brain membrane proteins
that is enriched for neuronal SNAREs (syntaxins, synaptobrevins, and
SNAP-25; (9) ). The resulting 20 S complexes were
immunoprecipitated using anti-syntaxin antibody (HPC1), and the amount
of NSF or mutant bound was determined by Western blotting. In each
case, only SNAP-dependent binding of the NSF or mutant protein was
considered significant. The lack of NSF or mutant bound to the
immunoprecipitable complex after MgATP addition is indicative of
particle disassembly.As in Fig. 1, the D1D2 mutant does not
exhibit SNAP-dependent binding to the 7 S complex, suggesting that the
N domain is a critical element of the interactions of NSF with other
components of the 20 S particle (Fig. 3A).
Surprisingly, the isolated N domain also failed to show SNAP-dependent
binding with the 7 S complex (Fig. 3A). This could
simply be due to improper folding of the recombinant domain. However,
this His -tagged protein is very stably expressed in E.
coli and migrates as a discrete peak of 28 kDa on gel filtration
chromatography (data not shown). The fact that the isolated, monomeric
N domain does not bind to the SNAP SNARE complex could reflect the
need for multiple contact points between NSF and the complex. A single
N domain might be incapable of interacting with enough of the requisite
binding sites. For the wild type NSF, these contacts could be formed
from the cooperative binding of more than one N domain in the context
of the trimer or could result from the recognition of more than one NSF
domain, i.e. N and D1. To try to address these
possibilities, two mutant forms of NSF were employed, N-D1 and N-D2.
N-D1 is monomeric (molecular mass = 80 kDa as determined by gel
exclusion chromatography) and has some ATPase activity (18% of wild
type; Table 1). The low level of ATPase activity is perhaps not
surprising because another oligomeric member (p97) of the family of
ATPases associated with a variety of cellular activities also has lower
ATPase activity when monomeric(27) . N-D2 is trimeric
(molecular mass = 186 kDa) but has no measurable ATPase activity (Table 1). The N-D1 truncate mutant binds to the 7 S complex in a
SNAP-dependent fashion with a low ( 10%) binding efficiency
compared with wild type NSF. With the addition of MgATP, the bound N-D1
protein releases from the complex in much the same way full-length NSF
does (Fig. 3A), but this truncated N-D1 possesses no
intra-Golgi transport activity even at very high concentrations (678
nM, data not shown). The N-D2 mutant also binds in a
SNAP-dependent fashion, again at much lower affinity, but the bound
protein does not release from the complex upon MgATP addition. This
same effect is also seen for the ND2D1 mutant (trimeric with ATPase
activity(14) ), which binds inefficiently and does not release
after MgATP addition (Fig. 3). From these data we conclude that
it is not simply the presence of the N domain that is important for
interaction with the SNAP SNARE complex but that it is the context
in which the N domain are presented. Isolated N domains fail to
interact with the SNAP SNARE complex, unless they are either
adjacent to a D1 domain, as would be the case for the wild type NSF and
the N-D1 mutant, or presented as a multimer, as would be the case for
the wild type NSF or the N-D2 and ND2D1 mutants. These two concepts are
not mutually exclusive but are most likely synergistic because none of
the mutants bind with the same efficiency as the wild type protein.
Inhibition of Golgi Transport by High Concentrations
of Domain Rearrangement MutantsAs demonstrated for the
hydrolysis mutants D1E-Q and D1E-Q/D2D-Q, a mutant that efficiently
binds to the SNAP SNARE complex but does not release upon MgATP
addition (Fig. 1) might be expected to be inhibitory to
intra-Golgi transport. A mutant that binds with low efficiency such as
the D1K-A mutant (Fig. 1B) would be expected to also
inhibit intra-Golgi transport but only at high concentrations. Two of
the rearrangement mutants, N-D2 and ND2D1, shown in Fig. 3have
a similar property in that they bind to the SNAP SNARE complex but
fail to release. Both proteins inhibited intra-Golgi transport but, as
expected from their low binding efficiencies, the concentrations needed
for significant inhibition were very high compared with that needed for
the D1E-Q mutant ( Fig. 4and (14) ). Because NSF is
required in such low amounts (0.2-0.4 nM(26) )
to saturate the intra-Golgi transport assay, the concentrations of
mutants originally tested were also low (63 nM). In the
experiments presented (Fig. 4), higher levels (2.5-fold more
than previously used) of the mutant proteins were needed for any
significant inhibition, which is consistent with their low binding
efficiencies (Fig. 3). It is unlikely that contaminating
proteins produce this inhibition because similarly purified, wild type
NSF and N-D1 proteins caused no decrease in intra-Golgi transport.
Interestingly, the N-D1 mutant that binds and can release in the
presence of MgATP does not show any inhibition of Golgi transport even
at the higher concentration, nor does it have any transport activity.
Apparently, the N-D1 protein can participate in complex formation and
utilizes ATP to facilitate its release from the complex, yet it is
unable to make all of the contacts required to complete the intra-Golgi
transport process. The fact that the binding studies ( Fig. 1and Fig. 3) were predictive of these inhibition experiments further
supports the biological relevance of the binding data.
Figure 4:
N-D2
and ND2D1 inhibit the Golgi transport activity but only at high
concentration. The indicated amounts of each of the proteins were added
to a standard (25 µl) intra-Golgi transport assay using wild type
Chinese hamster ovary cytosol as a source of soluble transport factors.
Intercisternal Golgi transport of marker protein from the mutant Golgi
complex (donor) to the wild type Golgi complex (acceptor) was measured
by the incorporation of [ H]GlcNAc into the
vesicular stomatitis virus G glycoprotein. The control 100% value was
5613 dpm with a background of 15 dpm. Abbreviations for the NSF mutants
are explained in the text.
Multiple Contact Sites Are Needed for Active NSF
TrimersThe results of earlier experiments (14) suggested that all three of the subunits in the NSF trimer
need to be active for the trimer to be functional. In light of the fact
that the D1D2 mutant is inactive in the intra-Golgi transport
assay(14) , it might be expected that mixed NSF/D1D2 trimers
containing one or two D1D2 subunits might be inactive as well. However,
the mixed trimeric molecules could have some Golgi transport activity
because they would possess at least one N domain and the full
complement of D1 domains, which as discussed above are required for
association with the SNAP SNARE complex. To test this,
His -tagged D1D2 myc was co-expressed in E.
coli together with an untagged form of wild type NSF. The
resulting trimers were isolated from E. coli extracts by
polyethylene glycol precipitation and fractionated by NiNTA-agarose
chromatography using an imidazole gradient, and NSF activity was
determined for each fraction. Fig. 5represents the results of
such an experiment with NSF/D1D2 mixed trimers. Any trimers that are
bound by the NiNTA agarose contain at least one of the truncated
subunits. Two peaks of transport activity are present in the elution
profile. The peak early in the profile represents wild type NSF trimers
that do not interact with the affinity resin. Because E. coli extracts have an inhibitory effect on Golgi transport, ( )the measurable NSF activity in the first peak is slightly
offset from the bulk of the excluded proteins. The second peak, eluted
by the imidazole gradient, represents the trimers that bind to the
NiNTA resin and, therefore, are a mixture of wild type and D1D2
subunits. This collection of trimers would be made up of molecules
possessing two, one, or no N domains. From this experiment we can
conclude that for a functional NSF trimer, three N domains are not
essential but at least one is required when it is presented in the
right context with the D1 domain. The position and shape of the second
activity peak, relative to the protein profile, indicates that trimers
eluting earlier in the imidazole gradient (containing fewer
His -tagged D1D2 myc subunits) account for the bulk
of the transport activity. This would suggest that trimers containing
two N domains are the active species, but further fractionation will be
required to determine this conclusively. These findings are consistent
with the concept that multiple contact sites are required for NSF to
interact with the other components of the 20 S fusion particle.
Figure 5:
Mixed wild type/D1D2 trimers are active in
intra-Golgi transport. His -D1D2 myc and untagged
NSF were co-expressed in E. coli, and the resulting mixed
trimeric molecules were partially purified by polyethylene glycol
precipitation and then subjected to fractionation on NiNTA-agarose
using a gradient of imidazole as eluent. The upper panel represents the profile of eluted protein as analyzed by
SDS-polyacrylamide gel electrophoresis followed by Coomassie Brilliant
Blue staining. In the lower panel, 0.4-µl aliquots were taken from
every third 1-ml fraction and assayed for NSF activity using N-ethylmaleimide-treated Golgi membranes under standard
reaction conditions as described under ``Experimental
Procedures.'' A background of 440 cpm was subtracted from each
data point.
DISCUSSION
In this manuscript we attempt to further understand the
functional features of NSF by examining which domains of the molecule
are required for which protein-protein interactions in the 20 S fusion
complex. To this end, we have demonstrated that interactions of
SNAP SNARE complex with NSF are primarily through the N domains of
the trimer. Consistent with this is the observation that the mutation
leading to the sec18-1 temperature-sensitive allele is
present in a region (ClaI fragment
Ile -Ile ) corresponding to the N domain
Sec18p(28) . This same mutant allele exhibits synthetic
lethality when combined with the sec17-1 mutant, which
is the yeast equivalent of -SNAP(3) . A secondary
interaction with the D1 domain of NSF also appears to play a role in 20
S particle formation, but only when D1 is adjacent to the N domain. ATP
binding by the D1 may be an important element for NSF to attain the
conformation needed for binding to 20 S particle, although this is not
completely clear because other replacements of lysine 266 do not
exhibit exactly the same inhibitory behavior(17) . One might
expect that the D1K-A mutant would have similar particle binding
properties to the wild type protein because both elements for binding,
trimerization and adjacency to the D1 domain, are present in the
molecule. The fact that D1K-A mutant can bind only weakly (like N-D2
and ND2D1), suggests that there may be a nucleotide-induced
conformational change in D1 that affects the N domain. We speculate
that binding of NSF to the SNAP SNARE complex may be promoted when
an appropriate nucleotide (ATP) is bound to the D1 domain. The mutant
proteins (especially the N-D1) described in this manuscript should aid
in dissecting the role of nucleotide binding to the D1 domain and its
relationship to NSF binding to the SNAP SNARE complex. The
amino acid sequences around the ATP-binding sites in the D1 and D2
domains are characteristic of the family of ATPases associated with a
variety of cellular activities(29) . Like NSF, these proteins
use ATP hydrolysis to carry out their distinctive cellular functions,
and mutations of their ATP-binding sites (especially in the domains
most homologous to D1) appear to affect the function of the proteins in
ways similar to that shown for NSF (discussed in (14) ). These
similarities between the various ATPases associated with a variety of
cellular activities suggest that a common mechanism might be used by
all of these proteins to carry out their varied cellular functions. In
this manuscript, we demonstrate that the ATPase activity of the D1
domain is directly required for fusion complex disassembly and that the
N domain is required for NSF localization. This concept that each
domain has a distinct contribution to the overall function of NSF may
prove to be a useful paradigm for the study of other ATPases associated
with a variety of cellular activities. The major role of the D2
domain is trimer formation, which appears to be essential for NSF
activity(26) . The isolated domain, expressed as a recombinant
protein in E. coli, is trimeric. ( )Earlier studies
showed that ATP binding and hydrolysis by this domain are not required
for intra-Golgi transport (14, 17) and, as shown in
this manuscript, these properties are also not required for 20 S
particle dynamics. The N-D2 and ND2D1 mutants bind to the
SNAP SNARE complex because the N domains are presented as a
trimer, but they cannot release once bound because they lack the
adjacent D1 domain. These data suggest that even when the D2 domain is
placed adjacent to the N domain in a chimeric molecule, it cannot mimic
the conformational effects that D1 exerts on the N domain. In
summary, the data presented here suggest roles for each of the three
domains of NSF. The N domain is required for SNAP SNARE complex
binding but must be either adjacent to the D1 domain or in a trimeric
configuration. These two structural features are most likely
synergistic, because neither alone is sufficient to promote the binding
efficiency seen for wild type NSF. The D1 domain must be able to
hydrolyze ATP to disassemble the 20 S particle, and therefore this step
is a required intermediate in the transport process. Consistent with
this observation is the recent discovery that the
temperature-sensitive, paralytic, mutant comatose is caused by a point mutation (equivalent to Gly to
Glu) in the Drosophila NSF gene near the D1 ATP-binding
site(30) . From the data presented in this manuscript, we
speculate that the binding of nucleotide (ATP) by D1 induces
conformational changes in the D1 and N domains that are critical to the
interaction of NSF with the other elements of the 20 S fusion particle.
In this way, only ATP-charged NSF would be capable of participating in
20 S particle formation. By pairing biochemical and structural
analyses, it should be possible to unravel the mechanism of NSF in
vesicular transport.
FOOTNOTES
- *
- This work was supported by
Grant CB-153 from the American Cancer Society (to S. W. W.) and by a
grant from the University of Kentucky Research Foundation (to S. W.
W.). The costs of publication of this article were defrayed in part by
the payment of page charges. This article must therefore by hereby
marked ``advertisement'' in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
- §
- To whom correspondence should be addressed:
Dept. of Biochemistry, University of Kentucky College of Medicine,
Chandler Medical Center, 800 Rose St., Lexington, KY 40536-0084. Tel.:
606-323-1065; Fax: 606-323-1037.
- (
) - The
abbreviations used are: NSF, N-ethylmaleimide-sensitive fusion
protein; SNAP, soluble NSF attachment protein; SNARE, SNAP receptor;
NiNTA, nickel nitrotriacetic acid; ATP
S, adenosine
5`-O-(3-thiotriphosphate). - (
) - S. W.
Whiteheart, unpublished observation.
- (
) - S. W.
Whiteheart and B. Boggess, unpublished observation.
ACKNOWLEDGEMENTS
We thank Paula Lemons and Dr. Susan A. Buhrow for
helpful discussions and critical reading of the manuscript. We also
thank Bridgette Boggess for technical assistance and Jim Smith for fine
photographic assistance.
REFERENCES
- Whiteheart, S. W., and Kubalek, E. W. (1995) Trends Cell Biol. 5, 64-68
[CrossRef][Medline]
[Order article via Infotrieve]
- Malhotra, V., Orci, L., Glick, B. S., Block, M. R., and Rothman, J. E. (1988) Cell 54, 221-227
[CrossRef][Medline]
[Order article via Infotrieve]
- Kaiser, C. A., and Schekman, R. (1990) Cell 61, 723-733
[CrossRef][Medline]
[Order article via Infotrieve]
- Hong, R.-M., Mori, H., Fukui, T., Moriyama, Y., Futai, M., Yamamoto, A., Tashiro, Y., and Tagaya, M. (1994) FEBS Lett. 350, 253-257
[CrossRef][Medline]
[Order article via Infotrieve]
- Wattenberg, B. W., Raub, T. J., Hiebsch, R. R., and Weidman, P. J. (1992) J. Cell Biol. 118, 1321-1332
[Abstract/Free Full Text]
- Rexach, M. F., and Schekman, R. W. (1991) J. Cell Biol. 114, 219-229
[Abstract/Free Full Text]
- Ostermann, J., Orci, L., Tani, K., Amherdt, M., Ravazzola, M., Elazar, Z., and Rothman, J. E. (1993) Cell 75, 1015-1025
[CrossRef][Medline]
[Order article via Infotrieve]
- Ikonen, E., Tagaya, M., Ullrich, O., Montecucco, C., and Simons, K. (1995) Cell 81, 571-580
[CrossRef][Medline]
[Order article via Infotrieve]
- Söllner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324
[CrossRef][Medline]
[Order article via Infotrieve]
- Weidman, P. J., Melançon, P., Block, M. R., and Rothman, J. E. (1989) J. Cell Biol. 108, 1589-1596
[Abstract/Free Full Text]
- Clary, D. O., Griff, I. C., and Rothman, J. E. (1990) Cell 61, 709-721
[CrossRef][Medline]
[Order article via Infotrieve]
- Wilson, D. W., Whiteheart, S. W., Wiedmann, M., Brunner, M., and Rothman, J. E. (1992) J. Cell Biol. 117, 531-538
[Abstract/Free Full Text]
- Söllner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., and Rothman, J. E. (1993) Cell 75, 409-418
[CrossRef][Medline]
[Order article via Infotrieve]
- Whiteheart, S. W., Rossnagel, K., Buhrow, S. A., Brunner, M., Jaenicke, R., and Rothman, J. E. (1994) J. Cell Biol. 126, 945-954
[Abstract/Free Full Text]
- Wilson, D. W., Wilcox, C. A., Flynn, G. C., Chen, E., Kuang, W., Henzel, W. J., Block, M. R., Ullrich, A., and Rothman, J. E. (1989) Nature 339, 355-359
[CrossRef][Medline]
[Order article via Infotrieve]
- Tagaya, M., Wilson, D. W., Brunner, M., Arango, N., and Rothman, J. E. (1993) J. Biol. Chem. 268, 2662-2666
[Abstract/Free Full Text]
- Sumida, M., Hong, R.-M., and Tagaya, M. (1994) J. Biol. Chem. 269, 20636-20641
[Abstract/Free Full Text]
- Morgan, A., Dimaline, R., and Burgoyne, R. D. (1994) J. Biol. Chem. 269, 29347-29350
[Abstract/Free Full Text]
- Evan, G. I., Lewis, G. K., Ramsay, G., and Bishop, M. J. (1985) Mol. Cell. Biol. 5, 3610-3616
[Abstract/Free Full Text]
- Inoue, A., Obata, K., and Akagawa, K. (1992) J. Biol. Chem. 267, 10613-10619
[Abstract/Free Full Text]
- Harlow, E., and Lane, D. (1988) Antibodies: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
- Whiteheart, S. W., Griff, I. C., Brunner, M., Clary, D. O., Mayer, T., Buhrow, S. A., and Rothman, J. E. (1993) Nature 362, 353-355
[CrossRef][Medline]
[Order article via Infotrieve]
- Whiteheart, S. W., Brunner, M., Wilson, D. W., Wiedmann, M., and Rothman, J. E. (1992) J. Biol. Chem. 267, 12239-12243
[Abstract/Free Full Text]
- Wilson, D. W., and Rothman, J. E. (1992) Methods Enzymol. 219, 309-318
[Medline]
[Order article via Infotrieve]
- Balch, W. E., and Rothman, J. E. (1985) Arch. Biochem. Biophys. 240, 413-425
[CrossRef][Medline]
[Order article via Infotrieve]
- Block, M. R., Glick, B. S., Wilcox, C. A., Wieland, F. T., and Rothman, J. E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 7852-7856
[Abstract/Free Full Text]
- Peters, J. M., Harris, J. R., Lustig, A., Müller, S., Engel, A., Volker, S., and Franke, W. W. (1992) J. Mol. Biol. 223, 557-571
[CrossRef][Medline]
[Order article via Infotrieve]
- Eakle, K. A., Bernstein, M., and Emr, S. D. (1988) Mol. Cell. Biol. 8, 4098-4109
[Abstract/Free Full Text]
- Kunau, W. H., Beyer, A., Franken, T., Götte, K., Marzioch, M., Saidowsky, J., Skaletz-Rorowski, A., and Wiebel, F. F. (1993) Biochimie (Paris) 75, 209-224
[Medline]
[Order article via Infotrieve]
- Pallanck, L., Odrway, R. W., and Ganetzky, B. (1995) Nature 376, 25
[Medline]
[Order article via Infotrieve]
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Xu and W. Wickner
Bem1p Is a Positive Regulator of the Homotypic Fusion of Yeast Vacuoles
J. Biol. Chem.,
September 15, 2006;
281(37):
27158 - 27166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, K. Cheng, K. Gong, A. K. Y. Fu, and N. Y. Ip
Pctaire1 Phosphorylates N-Ethylmaleimide-sensitive Fusion Protein: IMPLICATIONS IN THE REGULATION OF ITS HEXAMERIZATION AND EXOCYTOSIS
J. Biol. Chem.,
April 14, 2006;
281(15):
9852 - 9858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Beinker, S. Schlee, R. Auvula, and J. Reinstein
Biochemical Coupling of the Two Nucleotide Binding Domains of ClpB: COVALENT LINKAGE IS NOT A PREREQUISITE FOR CHAPERONE ACTIVITY
J. Biol. Chem.,
November 11, 2005;
280(45):
37965 - 37973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shorer, N. Amar, A. Meerson, and Z. Elazar
Modulation of N-Ethylmaleimide-sensitive Factor Activity upon Amino Acid Deprivation
J. Biol. Chem.,
April 22, 2005;
280(16):
16219 - 16226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Matsushita, C. N. Morrell, and C. J. Lowenstein
A Novel Class of Fusion Polypeptides Inhibits Exocytosis
Mol. Pharmacol.,
April 1, 2005;
67(4):
1137 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Gage, E. A. Matveeva, S. W. Whiteheart, and M. von Zastrow
Type I PDZ Ligands Are Sufficient to Promote Rapid Recycling of G Protein-coupled Receptors Independent of Binding to N-Ethylmaleimide-sensitive Factor
J. Biol. Chem.,
February 4, 2005;
280(5):
3305 - 3313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shiozawa, N. Maita, K. Tomii, A. Seto, N. Goda, Y. Akiyama, T. Shimizu, M. Shirakawa, and H. Hiroaki
Structure of the N-terminal Domain of PEX1 AAA-ATPase: CHARACTERIZATION OF A PUTATIVE ADAPTOR-BINDING DOMAIN
J. Biol. Chem.,
November 26, 2004;
279(48):
50060 - 50068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. V. Naismith, J. E. Heuser, X. O. Breakefield, and P. I. Hanson
From The Cover: TorsinA in the nuclear envelope
PNAS,
May 18, 2004;
101(20):
7612 - 7617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dalal, M. F. N. Rosser, D. M. Cyr, and P. I. Hanson
Distinct Roles for the AAA ATPases NSF and p97 in the Secretory Pathway
Mol. Biol. Cell,
February 1, 2004;
15(2):
637 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Puri, M. J. Kruhlak, S. W. Whiteheart, and P. A. Roche
Mast Cell Degranulation Requires N-Ethylmaleimide-Sensitive Factor-Mediated SNARE Disassembly
J. Immunol.,
November 15, 2003;
171(10):
5345 - 5352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. L. Yeo, L. Xu, J. Ren, V. J. Boulton, M. D. Wagle, C. Liu, G. Ren, P. Wong, R. Zahn, P. Sasajala, et al.
Vps20p and Vta1p interact with Vps4p and function in multivesicular body sorting and endosomal transport in Saccharomyces cerevisiae
J. Cell Sci.,
October 1, 2003;
116(19):
3957 - 3970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Wang, C. Song, X. Yang, and C.-C. H. Li
D1 Ring Is Stable and Nucleotide-independent, whereas D2 Ring Undergoes Major Conformational Changes during the ATPase Cycle of p97-VCP
J. Biol. Chem.,
August 29, 2003;
278(35):
32784 - 32793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tani, M. Shibata, K. Kawase, H. Kawashima, K. Hatsuzawa, M. Nagahama, and M. Tagaya
Mapping of Functional Domains of gamma -SNAP
J. Biol. Chem.,
April 4, 2003;
278(15):
13531 - 13538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Song, Q. Wang, and C.-C. H. Li
ATPase Activity of p97-Valosin-containing Protein (VCP). D2 MEDIATES THE MAJOR ENZYME ACTIVITY, AND D1 CONTRIBUTES TO THE HEAT-INDUCED ACTIVITY
J. Biol. Chem.,
January 31, 2003;
278(6):
3648 - 3655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nagahama, M. Suzuki, Y. Hamada, K. Hatsuzawa, K. Tani, A. Yamamoto, and M. Tagaya
SVIP Is a Novel VCP/p97-interacting Protein Whose Expression Causes Cell Vacuolation
Mol. Biol. Cell,
January 1, 2003;
14(1):
262 - 273.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Guo, M. R. Maurizi, L. Esser, and D. Xia
Crystal Structure of ClpA, an Hsp100 Chaperone and Regulator of ClpAP Protease
J. Biol. Chem.,
November 22, 2002;
277(48):
46743 - 46752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zakalskiy, G. Hogenauer, T. Ishikawa, E. Wehrschutz-Sigl, F. Wendler, D. Teis, G. Zisser, A. C. Steven, and H. Bergler
Structural and Enzymatic Properties of the AAA Protein Drg1p from Saccharomyces cerevisiae. DECOUPLING OF INTRACELLULAR FUNCTION FROM ATPase ACTIVITY AND HEXAMERIZATION
J. Biol. Chem.,
July 19, 2002;
277(30):
26788 - 26795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Pullikuth and S. S. Gill
In vivo membrane trafficking role for an insect N-ethylmaleimide-sensitive factor which is developmentally regulated in endocrine cells
J. Exp. Biol.,
April 1, 2002;
205(7):
911 - 926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Errico, A. Ballabio, and E. I. Rugarli
Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics
Hum. Mol. Genet.,
January 1, 2002;
11(2):
153 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Littleton, R. J. O. Barnard, S. A. Titus, J. Slind, E. R. Chapman, and B. Ganetzky
SNARE-complex disassembly by NSF follows synaptic-vesicle fusion
PNAS,
September 26, 2001;
(2001)
221450198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Michaut, C. N. Tomes, G. De Blas, R. Yunes, and L. S. Mayorga
Calcium-triggered acrosomal exocytosis in human spermatozoa requires the coordinated activation of Rab3A and N-ethylmaleimide-sensitive factor
PNAS,
August 17, 2000;
(2000)
180206197.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. J. Steel, C. Harley, A. Boyd, and A. Morgan
A Screen for Dominant Negative Mutants of SEC18 Reveals a Role for the AAA Protein Consensus Sequence in ATP Hydrolysis
Mol. Biol. Cell,
April 1, 2000;
11(4):
1345 - 1356.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Babor and D. Fass
Crystal structure of the Sec18p N-terminal domain
PNAS,
December 21, 1999;
96(26):
14759 - 14764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. He, R. C. Southard, D. Chen, S. W. Whiteheart, and R. L. Cooper
Role of alpha -SNAP in Promoting Efficient Neurotransmission at the Crayfish Neuromuscular Junction
J Neurophysiol,
December 1, 1999;
82(6):
3406 - 3416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Hartman and R. D. Vale
Microtubule Disassembly by ATP-Dependent Oligomerization of the AAA Enzyme Katanin
Science,
October 22, 1999;
286(5440):
782 - 785.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Karata, T. Inagawa, A. J. Wilkinson, T. Tatsuta, and T. Ogura
Dissecting the Role of a Conserved Motif (the Second Region of Homology) in the AAA Family of ATPases. SITE-DIRECTED MUTAGENESIS OF THE ATP-DEPENDENT PROTEASE FtsH
J. Biol. Chem.,
September 10, 1999;
274(37):
26225 - 26232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. McDonald, N. L. Cote, F.-T. Lin, R. T. Premont, J. A. Pitcher, and R. J. Lefkowitz
Identification of NSF as a beta -Arrestin1-binding Protein. IMPLICATIONS FOR beta 2-ADRENERGIC RECEPTOR REGULATION
J. Biol. Chem.,
April 16, 1999;
274(16):
10677 - 10680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Fleming, T. M. Hohl, R. C. Yu, S. A. Muller, B. Wolpensinger, A. Engel, H. Engelhardt, A. T. Brunger, T. H. Sollner, and P. I. Hanson
A Revised Model for the Oligomeric State of the N-Ethylmaleimide-sensitive Fusion Protein, NSF
J. Biol. Chem.,
June 19, 1998;
273(25):
15675 - 15681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Schweizer, T. Dresbach, W. M. DeBello, V. O'Connor, G. J. Augustine, and H. Betz
Regulation of Neurotransmitter Release Kinetics by NSF
Science,
February 20, 1998;
279(5354):
1203 - 1206.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. I. Colombo, S. C. Gelberman, S. W. Whiteheart, and P. D. Stahl
N-Ethylmaleimide-Sensitive Factor-dependent alpha -SNAP Release, an Early Event in the Docking/Fusion Process, Is Not Regulated by Rab GTPases
J. Biol. Chem.,
January 16, 1998;
273(3):
1334 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J.O. Barnard, A. Morgan, and R. D. Burgoyne
Stimulation of NSF ATPase Activity by alpha -SNAP Is Required for SNARE Complex Disassembly and Exocytosis
J. Cell Biol.,
November 17, 1997;
139(4):
875 - 883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Matveeva, P. He, and S. W. Whiteheart
N-Ethylmaleimide-sensitive Fusion Protein Contains High and Low Affinity ATP-binding Sites That Are Functionally Distinct
J. Biol. Chem.,
October 17, 1997;
272(42):
26413 - 26418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. Lemons, D. Chen, A. M. Bernstein, M. K. Bennett, and S.W. Whiteheart
Regulated Secretion in Platelets: Identification of Elements of the Platelet Exocytosis Machinery
Blood,
August 15, 1997;
90(4):
1490 - 1500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Colombo, M. Taddese, S. W. Whiteheart, and P. D. Stahl
A Possible Predocking Attachment Site for N-Ethylmaleimide-sensitive Fusion Protein. INSIGHTS FROM IN VITRO ENDOSOME FUSION
J. Biol. Chem.,
August 2, 1996;
271(31):
18810 - 18816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Matveeva, S. W. Whiteheart, T. C. Vanaman, and J. T. Slevin
Phosphorylation of the N-Ethylmaleimide-sensitive Factor Is Associated with Depolarization-dependent Neurotransmitter Release from Synaptosomes
J. Biol. Chem.,
April 6, 2001;
276(15):
12174 - 12181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Manifava, J. W. J. F. Thuring, Z.-Y. Lim, L. Packman, A. B. Holmes, and N. T. Ktistakis
Differential Binding of Traffic-related Proteins to Phosphatidic Acid- or Phosphatidylinositol (4,5)- Bisphosphate-coupled Affinity Reagents
J. Biol. Chem.,
March 16, 2001;
276(12):
8987 - 8994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wimmer, T. M. Hohl, C. A. Hughes, S. A. Muller, T. H. Sollner, A. Engel, and J. E. Rothman
Molecular Mass, Stoichiometry, and Assembly of 20 S Particles
J. Biol. Chem.,
July 27, 2001;
276(31):
29091 - 29097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Lamb, V. Fu, E. Wirtz, and J. D. Bangs
Functional Analysis of the Trypanosomal AAA Protein TbVCP with trans-Dominant ATP Hydrolysis Mutants
J. Biol. Chem.,
June 8, 2001;
276(24):
21512 - 21520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. May, S. W. Whiteheart, and W. I. Weis
Unraveling the Mechanism of the Vesicle Transport ATPase NSF, the N-Ethylmaleimide-sensitive Factor
J. Biol. Chem.,
June 15, 2001;
276(25):
21991 - 21994.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Michaut, C. N. Tomes, G. De Blas, R. Yunes, and L. S. Mayorga
Calcium-triggered acrosomal exocytosis in human spermatozoa requires the coordinated activation of Rab3A and N-ethylmaleimide-sensitive factor
PNAS,
August 29, 2000;
97(18):
9996 - 10001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Littleton, R. J. O. Barnard, S. A. Titus, J. Slind, E. R. Chapman, and B. Ganetzky
SNARE-complex disassembly by NSF follows synaptic-vesicle fusion
PNAS,
October 9, 2001;
98(21):
12233 - 12238.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|